Provectus Biopharmaceuticals Retains PharmaHEALTHLabs to Facilitate …PharmiWeb.com (press release)Provectus has completed phase 2 trials of PV-10 as a therapy for metastatic melanoma and of PH-10 as a topical treatment for atopic dermatitis and psoriasis. Information about these and the Company's other clinical trials including its current phase 3 …and more »
[monetize id=”1″]
[monetize id=”2″]
Novartis highlights strong innovation momentum at its second Meet Novartis …NasdaqIn Pharmaceuticals, we have a deep portfolio with Entresto (LCZ696) for chronic heart failure, Cosentyx for psoriasis, our newly acquired Oncology assets, and a strategy to lead in second generation immuno-oncology. At Alcon, IOL innovation is …and more »